Editor(s):
(1) Dr. Erich Cosmi, University of Padua, Italy.
(2) Prof. Darko Nozic, General hospital Acibadem Belmedic Belgrade, Serbia.
Reviewers:
(1) S.Tamijeselvan, Mother Theresa PG And Research Institute of Health Sciences, India.
(2) Gehanath Baral, Kathmandu University, Nepal.
(3) Rajlaxmi Patro, Roland Institute of Pharmaceutical Sciences Berhampur, India.
(4) Hirenkumar Mistry, USA.
Additional Reviewers:
(1) Chirag Mavani, DXC Technology, USA.
(2) Ravikumar Gurusamy, Anna University – M.P.Nachimuthu M.Jaganathan Engineering College, India.
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.5/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (S.Tamijeselvan, India) | File 1 | NA
Stage 2 | Peer Review Report_2 (Gehanath Baral, Nepal) | File 1 | NA
Stage 2 | Peer Review Report_3 (Rajlaxmi Patro, India) | File 1 | NA
Stage 2 | Peer Review Report_4 (Hirenkumar Mistry, USA) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA